Contrast-enhanced ultrasound market set to reach $2.84 billion by 2030

The Business Research Company says the global contrast-enhanced ultrasound market will grow from $2.13 billion in 2025 to $2.84 billion by 2030, driven by demand for non-radiation imaging, chronic disease management and broader use in cardiology and oncology. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Contrast-enhanced ultrasound is becoming a more important tool for diagnosing and monitoring disease without radiation exposure. - The market outlook points to steady demand across hospitals, point-of-care settings and specialty imaging applications. - Growth in chronic illness rates, including liver and vascular conditions, is expanding the need for real-time imaging.

What happened: - The Business Research Company released a 2026 market report on contrast-enhanced ultrasound on Aug. 1, 2026. - The report estimates the market will rise from $2.13 billion in 2025 to $2.26 billion in 2026. - The report projects the market will reach $2.84 billion by 2030. - The company places the market growth rate at 5.7% from 2025 to 2026 and 5.9% across the forecast period to 2030.

The details: - Contrast-enhanced ultrasound uses contrast agents, often microbubbles, to improve image clarity and detail. - The technique helps visualize blood flow and perfusion in organs. - CEUS also supports assessment of cardiac function by measuring blood flow rates in the heart and other tissues. - Historic growth has been supported by wider ultrasound adoption, stronger demand for radiation-free diagnostics, better access to contrast agents, advances in cardiovascular diagnostics and broader use in point-of-care settings. - Future growth is expected to come from demand for real-time functional imaging, higher investment in advanced diagnostic ultrasound systems, broader oncology use, non-invasive imaging preferences and approval of newer contrast agents. - Emerging trends include microbubble-based imaging agents, expanded cardiology and oncology applications, advanced ultrasound software, portable CEUS systems and more real-time perfusion imaging. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - Other regions covered in the report include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - Download a free sample of the report. - View the full market report.

Between the lines: - The report frames CEUS as a beneficiary of two durable healthcare shifts: the move toward non-invasive imaging and the need for better chronic disease monitoring. - The fastest growth in Asia-Pacific suggests room for broader adoption as healthcare infrastructure and diagnostic access expand. - The emphasis on portable systems and software points to a market that is moving beyond traditional imaging suites.

What's next: - The Business Research Company expects CEUS demand to keep rising through 2030 as new contrast agents and imaging platforms reach the market. - Broader oncology and cardiology use could open additional commercial opportunities for device makers and imaging software developers. - Providers and investors will likely watch Asia-Pacific capacity growth and regulatory approvals for newer agents as key market signals.

The bottom line: - Contrast-enhanced ultrasound is shifting from a specialized imaging option to a broader clinical growth market, with recurring demand tied to chronic disease care and non-radiation diagnostics.